Avatrombopag for severe refractory thrombocytopenia in a pediatric patient with ALL following allogeneic hematopoietic stem cell transplantation: A case report

Avatrombopag for severe refractory thrombocytopenia in a pediatric patient with ALL following allogeneic hematopoietic stem cell transplantation: A case report

Patients who receive allogeneic hematopoietic stem cell transplantation (alloHSCT) are at risk for developing persistent thrombocytopenia. Here, we describe treatment with avatrombopag, a thrombopoietin receptor agonist, in a pediatric patient with chronic, severe, transfusion-dependent thrombocytop...

Full description

Saved in:
Bibliographic Details
Main Authors: Emilie J. Lynch, Autumn Citta, Constance Alford, John A. Ligon, Mansi Dalal, Paul Castillo, Biljana Horn, Natalie Dotson, Giselle Moore-Higgs, Jordan Milner
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Leukemia Research Reports
Subjects:
Acute lymphoblastic leukemia
Allogeneic stem cell transplantation
Avatrombopag
Severe immune thrombocytopenia
Thrombopoietin receptor agonist
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048924000621
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2213048924000621

Similar Items